Endogenous regulators of angiogenesis - Emphasis on proteins with thrombospondin - Type I motifs

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 159-165

  Carpizo, D ^a   Iruela Arispe, M L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Proteins; Thrombospondin

Indexed keywords

ANGIOGENESIS INHIBITOR; THROMBOSPONDIN 1;

ANGIOGENESIS; CATALYSIS; COMPETITIVE INHIBITION; ENDOTHELIUM CELL; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADAM PROTEINS; ANGIOGENESIS INHIBITORS; ANIMALS; DISINTEGRINS; HUMANS; METALLOENDOPEPTIDASES; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSPONDIN 1;

EID: 0034534294     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026570331022     Document Type: Review

References (44)

1. The hallmarks of cancer
2. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ
3. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
4. Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF
5. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity
6. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
7. Angiostatin induces and sustains dormancy of human primary tumors in mice
8. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
9. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
10. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
11. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
12. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action
13. METH-1, a human ortholog of ADAMTS-1, and METH-1 are members of a new family of proteins with angio-inhibitory activity
14. Thrombospondins
15. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
16. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity
17. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of Thrombospondin-1
18. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats
19. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
20. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor
21. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
22. Membrane glycoprotein CD36: A review of its role in adherence, signal transduction, and transfusion medicine
23. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
24. Transforming growth factor-β complexes with thrombospondin
25. Thrombospondin-1 is a major activator of TGF-β1 in vivo
26. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
27. Integrin alpha V beta3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
28. Thrombospondin-1 is required for normal routine pulmonary homeostasis and its absence causes pneumonia
29. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis
30. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
31. Molecular mediators of angiogenesis in bladder cancer
32. Transfection of thrombospondin-1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
33. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
34. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
35. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization
36. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene
37. ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region
38. ADAMTS-1: A metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function
39. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat
40. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases
41. cDNA cloning and expression of bovine pro-collagen I N-proteinase: A new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components
42. ADAMTS: A novel family of proteases with an ADAM protease domain and thrombospondin I repeats
43. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
44. ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family